Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
1.050
-0.040 (-3.67%)
At close: Dec 5, 2025, 4:00 PM EST
1.020
-0.030 (-2.86%)
After-hours: Dec 5, 2025, 7:31 PM EST
Basel Medical Group Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| Operating Revenue | 11.32 | 10.05 | 9.7 | 10.66 |
| Other Revenue | 0.79 | 0.39 | 0.05 | - |
| Revenue | 12.11 | 10.44 | 9.75 | 10.66 |
| Revenue Growth (YoY) | 16.00% | 7.08% | -8.55% | - |
| Cost of Revenue | 8.92 | 5.89 | 5.58 | 2.72 |
| Gross Profit | 3.18 | 4.55 | 4.16 | 7.94 |
| Selling, General & Admin | 0.75 | 0.7 | 1.05 | 5.78 |
| Other Operating Expenses | 2.49 | 0.74 | 0.55 | -0.31 |
| Operating Expenses | 4.42 | 1.97 | 2.16 | 5.48 |
| Operating Income | -1.24 | 2.58 | 2 | 2.46 |
| Interest Expense | -0.2 | -0.18 | -0.24 | -0.32 |
| Interest & Investment Income | 0.08 | - | 0.3 | 0.25 |
| Other Non Operating Income (Expenses) | - | - | 0.07 | - |
| EBT Excluding Unusual Items | -1.36 | 2.4 | 2.13 | 2.39 |
| Impairment of Goodwill | -11.15 | - | - | - |
| Pretax Income | -12.51 | 2.4 | 2.13 | 2.39 |
| Income Tax Expense | -0.42 | 0.33 | 0.35 | 0.41 |
| Earnings From Continuing Operations | -12.09 | 2.07 | 1.78 | 1.98 |
| Minority Interest in Earnings | 0 | - | - | - |
| Net Income | -12.09 | 2.07 | 1.78 | 1.98 |
| Net Income to Common | -12.09 | 2.07 | 1.78 | 1.98 |
| Net Income Growth | - | 16.23% | -9.84% | - |
| Shares Outstanding (Basic) | 19 | 16 | 16 | 16 |
| Shares Outstanding (Diluted) | 19 | 16 | 16 | 16 |
| Shares Change (YoY) | 15.60% | - | - | - |
| EPS (Basic) | -0.64 | 0.13 | 0.11 | 0.12 |
| EPS (Diluted) | -0.64 | 0.13 | 0.11 | 0.12 |
| EPS Growth | - | 16.23% | -9.84% | - |
| Free Cash Flow | -15.39 | 2.5 | 2.59 | 2.7 |
| Free Cash Flow Per Share | -0.82 | 0.15 | 0.16 | 0.17 |
| Gross Margin | 26.29% | 43.59% | 42.71% | 74.48% |
| Operating Margin | -10.23% | 24.73% | 20.55% | 23.09% |
| Profit Margin | -99.84% | 19.86% | 18.30% | 18.56% |
| Free Cash Flow Margin | -127.08% | 23.97% | 26.61% | 25.37% |
| EBITDA | -1.13 | 2.61 | 2.03 | 2.48 |
| EBITDA Margin | -9.35% | 25.02% | 20.86% | 23.30% |
| D&A For EBITDA | 0.11 | 0.03 | 0.03 | 0.02 |
| EBIT | -1.24 | 2.58 | 2 | 2.46 |
| EBIT Margin | -10.23% | 24.73% | 20.55% | 23.09% |
| Effective Tax Rate | - | 13.80% | 16.34% | 17.12% |
Source: S&P Capital IQ. Standard template.
Financial Sources.